Immunogenicity of an inactivated Rift Valley fever vaccine in humans: a 12-year experience

By Pittman P.R.   Liu C.T.   Cannon T.L.   Makuch R.S.   Mangiafico J.A.   Gibbs P.H.   Peters C.J.  

Vaccine, Vol. 18, Iss. 1, 1999-08 ,pp. : 181-189

Elsevier

Access to resources Recommend Favorite

Evaluation of recombinant respiratory syncytial virus gene deletion mutants in African green monkeys for their potential as live attenuated vaccine candidates

By Jin H.   Cheng X.   Traina-Dorge V.L.   Park H.J.   Zhou H.   Soike K.   Kemble G.  

Vaccine, Vol. 21, Iss. 25, 2003-09 ,pp. : 3647-3652

Elsevier

Access to resources Recommend Favorite

The recombinant chimeric human parainfluenza virus type 1 vaccine candidate, rHPIV3-1cp45, is attenuated, immunogenic, and protective in African green monkeys

By Skiadopoulos M.H.   Tatem J.M.   Surman S.R.   Mitcho Y.   Wu S.-L.   Elkins W.R.   Murphy B.R.  

Vaccine, Vol. 20, Iss. 13, 2002-03 ,pp. : 1846-1852

Elsevier

Access to resources Recommend Favorite

Recombinant, chimaeric live, attenuated vaccine (ChimeriVax&unknown;) incorporating the envelope genes of Japanese encephalitis (SA14-14-2) virus and the capsid and nonstructural genes of yellow fever (17D) virus is safe, immunogenic and protective i

By Monath T.P.   Soike K.   Levenbook I.   Zhang Z.-X.   Arroyo J.   Delagrave S.   Myers G.   Barrett A.D.T.   Shope R.E.   Ratterree M.   Chambers T.J.   Guirakhoo F.  

Vaccine, Vol. 17, Iss. 15, 1999-04 ,pp. : 1869-1882

Elsevier

Access to resources Recommend Favorite

Potency testing of a live, genetically attenuated vaccine for salmonids

By Marsden M.J.   Vaughan L.M.   Fitzpatrick R.M.   Foster T.J.   Secombes C.J.  

Vaccine, Vol. 16, Iss. 11, 1998-07 ,pp. : 1087-1094

Elsevier

Access to resources Recommend Favorite